Open access
125
Views
15
CrossRef citations to date
0
Altmetric
Original Research
Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan
Jörg Mahlich1 Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan;2 Düsseldorf Institute for Competition Economics, University of Düsseldorf, Düsseldorf, GermanyCorrespondence[email protected]
, Masamichi Nishi3 Pricing, Janssen Pharmaceutical KK, Tokyo, Japan
& Yoshimichi Saito1 Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan
Pages 267-272
|
Published online: 22 May 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.